Research Article
Volume 4 Issue 1 - 2020
Tumor Lysis Syndrome Associated with Breast Cancer, a Previously Unrecognized Oncologic Emergency
Britney Bell2 and Jue Wang1,2,3**
1Creighton University School of Medicine, USA
2St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA
3University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center, USA
*Corresponding Author: Jue Wang, Professor of Medicine, University of Arizona Cancer Center at Dignity Health St. Joseph’s, Phoenix, AZ, USA.
Received: November 09, 2019; Published: December 06, 2019




Abstract

Background: Tumor lysis syndrome is a common oncologic emergency which has been well documented in patients suffering from hematologic malignancies. However, it is rarely reported in patients with solid tumors, even more rarely in patients with breast cancer. Many emergency room physicians, internists, even oncologists are not aware that TLS can actually occur in breast cancer. The objective of this study was to investigate the clinical characteristics and outcomes of TLS, a rare but life-threatening complication in breast cancer.

Methods: Retrospective literature review and pooled analysis.

Results: Twenty cases of TLS were identified in patients with breast cancer (19 case in published literature and 1 additional case from our tumor registry). The median age of patients was 57 years (31 - 94) with a female to male ratio of 19:1. All patients had extensive metastatic disease at the time of presentation, with visceral metastases documented in 100% of TLS cases. The in hospital mortality rate of entire cohort was 68%. The mortality rate for the patients developing treatment related TLS and spontaneous TLS were 50% and 75% respectively.

Conclusion: TLS in breast cancer can occur both after treatment and spontaneously and is associated with very high mortality. Our findings underscore the importance of heightened awareness, risk assessment and early prevention of this previously under-recognized oncologic emergency.

Keywords: Breast Cancer; Tumor Lysis Syndrome (TLS); Oncologic Emergency; Mortality

References

  1. Howard SC., et al. “The tumor lysis syndrome”. The New England Journal of Medicine 364 (2011): 1844-1854.
  2. Harmon J., et al. “The Clinical Features, Outcome and Prognosis of Spontaneous Tumor Lysis Syndrome in Solid Tumor”. Journal of Oncology Research Forecast 2 (2018): 1009.
  3. Cordrey EO and Wang J. “Tumor Lysis Syndrome Associated with Immune Checkpoint Blockade in Solid Tumors”. Japanese Journal of Cancer and Oncology Research 1 (2018): 1005.
  4. Harmon J., et al. “Liver Metastasis is an Independent Predictor for Mortality in Patients Who Developed Tumor Lysis Syndrome: Analysis of 132 Patients with Solid Tumors”. Journal of Clinical Oncology 15 (2018): e18766.
  5. Brunnhoelzl D and Wang J. “Acute Tumor Lysis Syndrome after Anti-PD1 Immunotherapy Nivolumab for Metastatic Melanoma”. Journal of Molecular Oncology Research 1 (2017): 5-6.
  6. Goyal H., et al. “Spontaneous fatal recurrent tumor lysis syndrome in ductal breast carcinoma”. Community Oncology4 (2012): 136-137.
  7. Elfar A., et al. “Spontaneous tumor lysis syndrome in breast cancer: a case report and discussion”. Journal of Cancer Therapeutics and Research 2 (2013): 9.
  8. Sklarin NT and Markham M. “Spontaneous recurrent tumor lysis syndrome in breast cancer”. American Journal of Clinical Oncology 1 (1995): 71-73.
  9. American Cancer Society. “Breast Cancer Facts and Figures”. American Cancer Society, Inc Atlanta: 2009-2010.
  10. Richards MA., et al. “Influence of delay on survival in patients with breast cancer: a systematic review”. Lancet9159 (1999): 1119-1126.
  11. Jassem J., et al. “Delays in diagnosis and treatment of breast cancer: a multinational analysis”. European Journal of Public Health 5 (2014): 761-776.
  12. Baudon C., et al. “Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report”. Journal of Medical Case Reports 10 (2016): 178.
  13. Barton JC. “Tumor lysis syndrome in non hematopoietic neoplasms”. Cancer3 (1989): 738-740.
  14. Baudon C., et al. “Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report”. Journal of Medical Case Reports1 (2016).
  15. Cech P., et al. “Tumor Lysis Syndrome after Tamoxifen Flare”. The New England Journal of Medicine4 (1986): 263-264.
  16. Drakos P., et al. “Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature”. American Journal of Clinical Oncology 6 (1994): 502-505.
  17. Kurt M., et al. “Tumor lysis syndrome following a single dose of capecitabine”. Annals of Pharmacotherapy5 (2004): 902-902.
  18. Mott FE., et al. “Tumor Lysis Syndrome in Solid Tumors”. Supportive Cancer Therapy3 (2005): 188-191.
  19. Rostom AY., et al. “Tumor lysis syndrome following hemi-body irradiation for metastatic breast cancer”. Annals of Oncology 10 (2000): 1349-1351.
  20. Stark ME., et al. “Fatal acute tumor lysis syndrome with metastatic breast carcinoma”. Cancer4 (1987): 762-764.
  21. Taira F., et al. “Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature”. Breast Cancer6 (2015): 664-668.
  22. Üstündağ Y., et al. “Acute tumor lysis syndrome associated with paclitaxel”. Annals of Pharmacotherapy12 (1997): 1548-1549.
  23. Vaidya GN and Acevedo R. “Tumor lysis syndrome in metastatic breast cancer after a single dose of paclitaxel”. The American Journal of Emergency Medicine2 (2015): 308.e1-308.e2.
  24. Cordrey EO., et al. “Spontaneous Tumor Lysis Syndrome in a Giant Neglected Breast Cancer”. Journal of Molecular Oncology Research 2 (2018): 1-4.
  25. Kaplan GG., et al. “Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma”. BMC Cancer1 (2005).
  26. Frestad D., et al. “Acute onset and rapid progression of multiple organ failure in a young adult with undiagnosed disseminated colonic adenocarcinoma”. Case Reports (2014).
Citation: Britney Bell and Jue Wang. “Tumor Lysis Syndrome Associated with Breast Cancer, a Previously Unrecognized Oncologic Emergency”. EC Emergency Medicine and Critical Care 4.1 (2020): 01-05.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


October Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the October issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for November Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the November issue of respective journals. Submissions are accepted on/before October 31, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk